In general, strive to use antibiotics covering a spectrum no broader than necessary and narrow the antibiotic spectrum of treatment ... Mild Clostridium difficile infection (CDI; stool frequency ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart ...

St. Louis-based Washington University School of Medicine researchers found that fidaxomicin, a treatment for Clostridioides difficile infection, has increased in use but "remains underutilized." ...

After using her brother as a donor, Koepke reported that her symptoms got better, amazingly she started developing acne like ...

Laboratory mice with cognitive issues including Alzheimer’s disease showed improved memory skills within a couple of weeks of treatment with a new medicine tested at Colorado State University.

In its first-quarter update, Seres said the product had made sales of around $10 million – almost $5 million of that total in March alone, with more than 1,000 new patients starting treatment in ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...